,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,880,2,1,,29216304,638678,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
1,880,2,1,,29216304,638678,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
2,1195,1,2,,48416492,638678,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
3,1469,1,1,,29216304,638678,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
4,1471,2,1,,29216304,638678,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
5,1479,1,2,,29216304,638678,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
6,1487,1,1,,29216304,638678,Inconclusive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
7,1490,2,1,,29216304,638678,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
8,1688,1,1,,29216304,638678,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
9,1766,1,1,,29216304,638678,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
10,1766,1,1,,29216304,638678,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
11,1768,1,1,,29216304,638678,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
12,1768,1,1,,29216304,638678,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
13,2528,1,2,,29216304,638678,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
14,2546,1,1,,29216304,638678,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
15,2551,1,1,,29216304,638678,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
16,2662,2,1,,29216304,638678,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
17,107460,2,4,,103538380,638678,Inactive,,,,,Compound was tested for motor impairment in mice by neuropharmacological test; No effect,Other,,
18,107461,2,4,,103538380,638678,Inactive,,,,,Compound was tested for myorelaxant action in mice by neuropharmacological test; No effect,Other,,
19,107465,2,4,,103538380,638678,Inactive,,,,,Compound was tested for psychomotor activation on CNS in mice by neuropharmacological test; No effect,Other,,
20,107470,2,4,,103538380,638678,Inactive,,,,,Compound was tested for sedative action in mice by neuropharmacological test; No effect,Other,,
21,118380,3,3,,103538380,638678,Unspecified,,,,,Activity was evaluated in C57BL/10 mice by Morris water Maze test and mean latency for TRH was reported at 0.001 mg/Kg i.p. dosage.,Other,7636847.0,
22,118381,3,3,,103538380,638678,Unspecified,,,,,Activity was evaluated in C57BL/10 mice by Morris water Maze test and mean latency for TRH was reported at 0.003 mg/Kg i.p. dosage.,Other,7636847.0,
23,118383,3,3,,103538380,638678,Unspecified,,,,,Activity was evaluated in C57BL/10 mice by Morris water Maze test and mean latency for TRH was reported at 0.01 mg/Kg i.p. dosage.,Other,7636847.0,
24,118385,3,3,,103538380,638678,Unspecified,,,,,Activity was evaluated in C57BL/10 mice by Morris water Maze test and mean latency for TRH was reported at 0.03 mg/Kg i.p. dosage.,Other,7636847.0,
25,118387,3,3,,103538380,638678,Unspecified,,,,,Activity was evaluated in C57BL/10 mice by Morris water Maze test and mean latency for TRH was reported at 0.1 mg/Kg i.p. dosage.,Other,7636847.0,
26,118389,3,3,,103538380,638678,Unspecified,,,,,Activity was evaluated in C57BL/10 mice by Morris water Maze test and mean latency for TRH was reported at 0.3 mg/Kg i.p. dosage.,Other,7636847.0,
27,118391,3,3,,103538380,638678,Unspecified,,,,,Activity was evaluated in C57BL/10 mice by Morris water Maze test and mean latency for TRH was reported at 1.0 mg/Kg i.p. dosage.,Other,7636847.0,
28,118392,3,3,,103538380,638678,Unspecified,,,,,Activity was evaluated in C57BL/10 mice by Morris water Maze test and mean latency for TRH was reported at 10.0 mg/Kg i.p. dosage.,Other,7636847.0,
29,118395,3,3,,103538380,638678,Unspecified,,,,,Activity was evaluated in C57BL/10 mice by Morris water Maze test and mean latency for TRH was reported at 3.0 mg/Kg i.p. dosage.,Other,7636847.0,
30,119184,3,3,,103538380,638678,Unspecified,,,,,Time of recovery of righting reflux (RRT) in seconds was measured after administration of 2.5 mg/kg intravenously in mice for the promotional effect on recovery from coma,Other,1676756.0,
31,119195,3,3,,103538380,638678,Unspecified,,,,,Time of recovery of righting reflux (RRT) in seconds was measured after iv administration of 0.625 mg/kg in mice for the promotional effect on recovery from coma.,Other,1676757.0,
32,119196,3,3,,103538380,638678,Unspecified,,,,,Time of recovery of righting reflux (RRT) in seconds was measured after iv administration of 1.25 mg/kg in mice for the promotional effect on recovery from coma.,Other,1676757.0,
33,119197,4,3,,103538380,638678,Unspecified,,,,,Time of recovery of righting reflux (RRT) in seconds was measured after iv administration of 2.5 mg/kg in mice for the promotional effect on recovery from coma.,Other,1676757.0,
34,119401,3,3,,103538380,638678,Unspecified,,,,,Time of recovery of spontaneous movement (SMT) in seconds was measured after administration of 2.5 mg/kg intravenously in mice for the promotional effect on recovery from coma,Other,1676756.0,
35,119410,3,3,,103538380,638678,Unspecified,,,,,Time of recovery of spontaneous movement (SMT) in seconds was measured after iv administration of 0.625 mg/kg in mice for the promotional effect on recovery from coma.,Other,1676757.0,
36,119411,3,3,,103538380,638678,Unspecified,,,,,Time of recovery of spontaneous movement (SMT) in seconds was measured after iv administration of 1.25 mg/kg in mice for the promotional effect on recovery from coma.,Other,1676757.0,
37,119412,4,3,,103538380,638678,Unspecified,,,,,Time of recovery of spontaneous movement (SMT) in seconds was measured after iv administration of 2.5 mg/kg in mice for the promotional effect on recovery from coma.,Other,1676757.0,
38,119414,3,3,,103538380,638678,Unspecified,,,,,Compound was tested for the anesthetic effect and the sleeping time (ST) was recorded at a dose of 0.3 mg/kg administered intraperitoneally.,Other,1676757.0,
39,119417,3,3,,103538380,638678,Unspecified,,,,,Compound was tested for the anesthetic effect and the sleeping time (ST) was recorded at a dose of 1 mg/kg administered intraperitoneally.,Other,1676757.0,
40,119420,3,3,,103538380,638678,Unspecified,,,,,Compound was tested for the anesthetic effect and the sleeping time (ST) was recorded at a dose of 3 mg/kg administered intraperitoneally.,Other,1676757.0,
41,119423,3,3,,103538380,638678,Unspecified,,,,,Antihypoxic effect by the ratio of survival time (SVT) of test mice to that of control group at a dose of 0.3 mg/kg administered intraperitoneally.,Other,1676757.0,
42,119427,3,3,,103538380,638678,Unspecified,,,,,Antihypoxic effect by the ratio of survival time (SVT) of test mice to that of control group at a dose of 1 mg/kg administered intraperitoneally.,Other,1676757.0,
43,119429,4,3,,103538380,638678,Unspecified,,,,,"Antihypoxic effect tested by the ratio of survival time (SVT) of test mice to that of control group, dosed intraperitoneally at 30 mg/kg",Other,1676757.0,
44,119432,3,3,,103538380,638678,Unspecified,,,,,Antihypoxic effect by the ratio of survival time (SVT) of test mice to that of control group at a dose of 3 mg/kg administered intraperitoneally.,Other,1676757.0,
45,119555,3,3,,103538380,638678,Inconclusive,,,,,Antihypoxic effect by the survival time (SVT) in mice at a dose of 100 mg/kg administered orally in mice; NT indicates not tested,Other,1676756.0,
46,119565,3,3,,103538380,638678,Unspecified,,,,,Antihypoxic effect by the survival time (SVT) in mice at a dose of 3 mg/kg administered intravenously in mice,Other,1676756.0,
47,119739,4,4,,103538380,638678,Unspecified,,,,,Reduction of hexobarbital induced sleeping time in mice.,Other,3091831.0,
48,168135,4,6,,103538380,638678,Unspecified,,,,,Evaluated for hormonal (TSH) releasing activity in adult male albino rats after single intraperitoneal injection using radioimmunoassay,Other,6429332.0,
49,171620,3,3,,103538380,638678,Unspecified,,,,,Thyrotropin releasing activity (TSH) was evaluated by measuring the TSH response to the compound by radioimmunoassay in two doses in the rat,Other,3091831.0,
50,176901,6,2,,103538380,638678,Unspecified,,,,,Dose that inhibited cataleptic effect of haloperidol in rat by 50%,Other,3091831.0,
51,178275,6,2,,103538380,638678,Unspecified,,,,,Anticataleptic effect at effective dose after intravenous administration in adult male Wistar rats.,Other,6429332.0,
52,182521,3,3,,103538380,638678,Unspecified,,,,,Ability of 80 mg/kg to inhibit the cataleptic effect of haloperidol in rat,Other,3091831.0,
53,183241,3,3,,103538380,638678,Unspecified,,,,,"Inhibition of haloperidol catalepsy by less than 50% in a dose of 80 mg/kg, iv in adult male Wistar rats",Other,6429332.0,
54,189561,3,3,,103538380,638678,Unspecified,,,,,Agonist activity relative to TRH (Thyroliberin) was evaluated in rat at a dose of 0.6 ng,Other,6267279.0,
55,190954,3,3,,103538380,638678,Unspecified,,,,,The thyrotropin (TSH) releasing activity was measured as serum TSH at 0.125 ug/rat dose (i.v.),Other,2115588.0,
56,190955,3,3,,103538380,638678,Unspecified,,,,,The thyrotropin (TSH) releasing activity was measured as serum TSH at 0.5 ug/rat dose (i.v.),Other,2115588.0,
57,190956,3,3,,103538380,638678,Unspecified,,,,,The thyrotropin (TSH) releasing activity was measured as serum TSH at 0.03125 ug/rat dose (i.v.),Other,2115588.0,
58,210544,7,2,,103538380,638678,Active,,,0.01,Ki,Binding affinity against TRH-R receptor in AtT-20 mouse pituitary tumor cells,Confirmatory,8648595.0,
59,213190,7,1,,103538380,638678,Active,,,0.00049,EC50,Ability to activate thyroliberin endocrine receptor (TRH-R) using AtT-20 mouse pituitary tumor cells prelabelled with myo-[3H] inositol,Confirmatory,9873682.0,
60,213191,7,1,,103538380,638678,Active,,,0.023,Ki,Ability to bind thyroliberin endocrine receptor (TRH-R) using AtT-20 mouse pituitary tumor cells.,Confirmatory,9873682.0,
61,213192,7,2,,103538380,638678,Active,,,0.0006799999999999999,EC50,Effective concentration required to activate TRH-R receptor in AtT-20 mouse pituitary tumor cells,Confirmatory,8648595.0,
62,222711,4,3,,103538380,638678,Unspecified,,,,,Effect on recovery time for coma induced in mice by cerebral concussion (control group),Other,10649973.0,
63,222712,4,3,,103538380,638678,Unspecified,,,,,Effect on recovery time for coma induced in mice by cerebral concussion (treated group),Other,10649973.0,
64,223173,3,4,,103538380,638678,Unspecified,,,,,Effect on the sleeping time of mice anesthetized with halothane (treated group),Other,10649973.0,
65,223176,4,4,,103538380,638678,Unspecified,,,,,Effect on the sleeping time of mice before halothane load (control group),Other,10649973.0,
66,229207,5,1,,103538380,638678,Inconclusive,,,,,Binding affinity for sigma receptors was evaluated by the inhibitory effect on [3H]DTG to rat whole brain membranes;NT means not tested.,Other,10649973.0,
67,229703,3,3,,103538380,638678,Unspecified,,,,,Evaluated for the potency ratio from the dose-response curve of TRH and compound by the parallel line assay method.,Other,2115588.0,
68,237091,5,2,,103538380,638678,Unspecified,,,,,Half-life of compound in rat plasma was determined,Other,15537357.0,
69,237121,5,2,,103538380,638678,Unspecified,,,,,Half-life of compound in rat brain homogenate was determined,Other,15537357.0,
70,237435,3,3,,103538380,638678,Unspecified,,,,,Partition coefficient (logP),Other,15537357.0,
71,237437,3,3,,103538380,638678,Unspecified,,,,,Calculated partition coefficient (clogP),Other,15537357.0,
72,237439,3,3,,103538380,638678,Unspecified,,,,,Calculated partition coefficient (clogP),Other,15537357.0,
73,237548,3,3,,103538380,638678,Unspecified,,,,,Capacity factor of compound was determined by immobilized artificial membrane chromatography,Other,15537357.0,
74,239477,12,1,,103538380,638678,Active,267163.0,25570.0,0.0423,Ki,Inhibition of [3H][3-Me-His2]-TRH binding to thyrotropin releasing hormone receptor of rat forebrain,Confirmatory,15537357.0,
75,252567,3,4,,103538380,638678,Unspecified,,,,,Sleeping time of mice was determined after intravenous administration of compound at 15 umol/kg of Body Weight,Other,15537357.0,
76,252621,3,4,,103538380,638678,Unspecified,,,,,Maximal changes in rat hippocampal acetylcholine concentration after administration of compound through a microdialysis probe,Other,15537357.0,
77,254533,9,4,,103538380,638678,Active,,,0.01,Ki,Inhibitory constant against thyrotropin releasing hormone receptor 2 expressed in HEK 293EM cells upon incubation at 37 degree C for 1 hr at pH 7.4 using [3H]Ntau(1)-Me-His-TRH,Confirmatory,16162016.0,
78,254556,9,1,,103538380,638678,Active,,,0.02,Ki,Inhibitory constant against thyrotropin releasing hormone receptor 1 expressed in HEK 293EM cells upon incubation at 37 degree C for 1 hr at pH 7.4 using [3H]Ntau(1)-Me-His-TRH; Range = 0.001-0.003 uM,Confirmatory,16162016.0,
79,254651,9,4,,103538380,638678,Active,,,0.003,EC50,Signaling (activation) potency for thyrotropin releasing hormone receptor 2 expressed in HEK 293EM cells with CREB-luciferase reporter upon incubation with the compound for 6 hr at 37 degree C and pH 7.8,Confirmatory,16162016.0,
80,254657,9,1,,103538380,638678,Active,,,0.003,EC50,Signaling (activation) potency for thyrotropin releasing hormone receptor 1 expressed in HEK 293EM cells with CREB-luciferase reporter upon incubation with the compound for 6 hr at 37 degree C and pH 7.8; Range = 0.002-0.004 uM,Confirmatory,16162016.0,
81,255368,3,6,,103538380,638678,Unspecified,,,,,Selectivity for thyrotropin releasing hormone receptor 2 measured as ratio of Ki towards THR-R1 to that of THR-R2,Other,16162016.0,
82,283905,9,2,,103538380,638678,Active,,,0.02,Ki,Displacement of [3H]N(1)-Me-His-TRH from TRHR1,Confirmatory,17035026.0,
83,283906,9,5,,103538380,638678,Active,,,0.01,Ki,Displacement of [3H]N(1)-Me-His-TRH from TRHR2,Confirmatory,17035026.0,
84,283907,6,3,,103538380,638678,Active,,,0.003,EC50,Agonist activity at TRHR1 expressed in HEK293EM cells assessed as activation potency by measuring CREB-luciferase reporter activity,Confirmatory,17035026.0,
85,283908,6,6,,103538380,638678,Active,,,0.003,EC50,Agonist activity at TRHR2 expressed in HEK293EM cells assessed as activation potency by measuring CREB-luciferase reporter activity,Confirmatory,17035026.0,
86,299831,7,1,,103538380,638678,Unspecified,,,,,Apparent permeability across human Caco-2 cells,Other,17498958.0,
87,299832,3,4,,103538380,638678,Unspecified,,,,,Stability in Caco-2 cells after 20 mins,Other,17498958.0,
88,299834,5,2,,103538380,638678,Unspecified,,,,,Stability in Caco-2 cells assessed as half life,Other,17498958.0,
89,384275,11,2,,103538380,638678,Active,81917833.0,,0.023,IC50,Displacement of [3H]3-methylhistidyl-TRH from rat recombinant TRHR2 expressed in HEK2935 cells,Confirmatory,18407692.0,
90,385236,9,5,,103538380,638678,Active,81917833.0,,23.0,IC50,Displacement of [3H]3-methylhistidyl-TRH from rat recombinant TRH2 receptor expressed in HEK2935 cells,Confirmatory,18412395.0,
91,485290,1,1,,29216304,638678,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
92,492961,1,1,,29216304,638678,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
93,504327,1,1,,29216304,638678,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
94,504332,1,1,,29216304,638678,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
95,504749,1,3,,29216304,638678,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
96,504749,1,3,1.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
97,504749,1,3,2.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
98,504749,1,3,3.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
99,504749,1,3,4.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
100,504749,1,3,5.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
101,504749,1,3,6.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
102,504749,1,3,7.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
103,504749,1,3,8.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
104,504749,1,3,9.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
105,504749,1,3,10.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
106,504749,1,3,11.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
107,504749,1,3,12.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
108,504749,1,3,13.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
109,504749,1,3,14.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
110,504749,1,3,15.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
111,504749,1,3,16.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
112,504749,1,3,17.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
113,504749,1,3,18.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
114,504749,1,3,19.0,29216304,638678,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
115,504749,1,3,20.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
116,504749,1,3,21.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
117,504749,1,3,22.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
118,504749,1,3,23.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
119,504749,1,3,24.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
120,504749,1,3,25.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
121,504749,1,3,26.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
122,504749,1,3,27.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
123,504749,1,3,28.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
124,504749,1,3,29.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
125,504749,1,3,30.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
126,504749,1,3,31.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
127,504749,1,3,32.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
128,504749,1,3,33.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
129,504749,1,3,34.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
130,504749,1,3,35.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
131,504749,1,3,36.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
132,504749,1,3,37.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
133,504749,1,3,38.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
134,504749,1,3,39.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
135,504749,1,3,40.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
136,504749,1,3,41.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
137,504749,1,3,42.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
138,504749,1,3,43.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
139,504749,1,3,44.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
140,504749,1,3,45.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
141,504749,1,3,46.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
142,504749,1,3,47.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
143,504749,1,3,48.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
144,504749,1,3,49.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
145,504749,1,3,50.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
146,504749,1,3,51.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
147,504749,1,3,52.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
148,504749,1,3,53.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
149,504749,1,3,54.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
150,504749,1,3,55.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
151,504749,1,3,56.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
152,504749,1,3,57.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
153,504749,1,3,58.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
154,504749,1,3,59.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
155,504749,1,3,60.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
156,504749,1,3,61.0,29216304,638678,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
157,504832,1,1,,29216304,638678,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
158,504834,1,1,,29216304,638678,Inconclusive,,,3.0131,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
159,504847,1,1,,29216304,638678,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
160,504865,1,1,,29216304,638678,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
161,588579,1,1,,29216304,638678,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
162,588834,2,1,,144205492,638678,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
163,602332,1,1,,29216304,638678,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
164,624030,1,2,,29216304,638678,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
165,624031,1,2,,29216304,638678,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
166,624032,1,2,,29216304,638678,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
167,624044,1,2,,29216304,638678,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
168,624170,1,1,,29216304,638678,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
169,624172,1,1,,29216304,638678,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
170,624173,1,3,,29216304,638678,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
171,624296,1,1,,29216304,638678,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
172,624297,1,1,,29216304,638678,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
173,651631,4,1,,144205492,638678,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
174,651632,4,1,,144205492,638678,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
175,651633,4,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
176,651634,4,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
177,652048,1,2,,144205492,638678,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
178,652051,1,1,,144205492,638678,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
179,686978,1,1,,144205492,638678,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
180,686979,1,1,,144205492,638678,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
181,720516,2,1,,144205492,638678,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
182,720532,1,1,,144205492,638678,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
183,720533,1,1,,144205492,638678,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
184,720552,2,1,,144205492,638678,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
185,720634,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
186,720635,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
187,720637,2,1,,144205492,638678,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
188,720674,2,2,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
189,720675,2,2,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
190,720678,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
191,720679,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
192,720680,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
193,720681,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
194,720682,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
195,720683,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
196,720684,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
197,720685,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
198,720686,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
199,720687,2,2,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
200,720691,4,1,,144205492,638678,Inactive,311348376.0,2908.0,6.007000000000001,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
201,720692,3,1,,144205492,638678,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
202,720693,3,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
203,720719,2,1,,144205492,638678,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
204,720725,2,1,,144205492,638678,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
205,743012,3,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
206,743014,3,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
207,743015,3,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
208,743033,3,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
209,743035,2,1,,144205492,638678,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
210,743036,2,1,,144205492,638678,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
211,743040,3,1,,144205492,638678,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
212,743041,3,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
213,743042,3,1,,144205492,638678,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
214,743053,2,1,,144205492,638678,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
215,743054,2,1,,144205492,638678,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
216,743063,2,1,,144205492,638678,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
217,743064,3,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
218,743065,3,1,,144205492,638678,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
219,743066,3,1,,144205492,638678,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
220,743067,2,1,,144205492,638678,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
221,743069,2,1,,144205492,638678,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
222,743074,2,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
223,743075,2,1,,144205492,638678,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
224,743077,2,1,,144205492,638678,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
225,743078,2,1,,144205492,638678,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
226,743079,3,1,,144205492,638678,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
227,743080,3,1,,144205492,638678,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
228,743081,3,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
229,743083,3,1,,144205492,638678,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
230,743084,3,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
231,743085,3,1,,144205492,638678,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
232,743086,3,1,,144205492,638678,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
233,743091,2,1,,144205492,638678,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
234,743094,3,1,,144205492,638678,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
235,743122,2,1,,144205492,638678,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
236,743139,2,1,,144205492,638678,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
237,743140,2,1,,144205492,638678,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
238,743244,1,1,,144205492,638678,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
239,1117301,1,2,,144205492,638678,Inactive,,,3.9811,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel",Confirmatory,,
240,1117302,1,2,,144205492,638678,Inactive,,,3.1623,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel",Confirmatory,,
241,1117303,1,2,,144205492,638678,Inactive,,,28.19,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel",Confirmatory,,
242,1117311,1,1,,144205492,638678,Inactive,,,3.98107,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel",Confirmatory,,
243,1117315,1,1,,144205492,638678,Inactive,,,3.16228,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel",Confirmatory,,
244,1117318,1,1,,144205492,638678,Inactive,,,28.1838,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel",Confirmatory,,
245,1239063,1,1,,103538380,638678,Unspecified,,,,,Half life in human plasma,Other,26216015.0,
246,1239064,1,1,,103538380,638678,Active,136205.0,22045.0,0.0026,IC50,Displacement of [3H]-1-MeHis-TRH from mouse TRH-R1 expressed in HEK293 cells incubated up to 4 hrs by scintillation counting method,Confirmatory,26216015.0,
247,1239065,1,1,,103538380,638678,Active,81917387.0,,0.006999999999999999,IC50,Displacement of [3H]-1-MeHis-TRH from mouse TRH-R2 expressed in HEK293 cells incubated up to 4 hrs by scintillation counting method,Confirmatory,26216015.0,
248,1239066,1,1,,103538380,638678,Active,136205.0,22045.0,0.001,EC50,Agonist activity at mouse TRH-R1 expressed in HEK293 cells assessed as induction of changes in intracellular Ca2+ level by FLIPR method,Confirmatory,26216015.0,
249,1239067,1,1,,103538380,638678,Active,81917387.0,,0.0005200000000000001,EC50,Agonist activity at mouse TRH-R2 expressed in HEK293 cells assessed as induction of changes in intracellular Ca2+ level by FLIPR method,Confirmatory,26216015.0,
250,1239068,1,1,,103538380,638678,Unspecified,,,,,"Selectivity index, ratio of EC50 for agonist activity at mouse TRH-R1 expressed in HEK293 cells to EC50 for agonist activity at mouse TRH-R2 expressed in HEK293 cells",Other,26216015.0,
251,1239069,1,1,,103538380,638678,Unspecified,,,,,"Reduction in pentobarbital-induced sleeping time in Swiss mouse at 10 umol/kg, iv",Other,26216015.0,
252,1239073,1,1,,103538380,638678,Unspecified,,,,,"Plasma concentration in Sprague-Dawley rat assessed as TSH level at 10 umol/kg, iv after 15 mins by ELISA method (Rvb = 5.52 ng/ml)",Other,26216015.0,
253,1239074,1,1,,103538380,638678,Unspecified,,,,,"Plasma concentration in Sprague-Dawley rat assessed as TSH level at 10 umol/kg, iv after 30 mins by ELISA method (Rvb = 5.52 ng/ml)",Other,26216015.0,
254,1239075,1,1,,103538380,638678,Unspecified,,,,,"Plasma concentration in Sprague-Dawley rat assessed as TSH level at 10 umol/kg, iv after 45 mins by ELISA method (Rvb = 5.52 ng/ml)",Other,26216015.0,
255,1239076,1,1,,103538380,638678,Unspecified,55583946.0,237553.0,,,Stability assessed as mouse recombinant TRH-degrading ectoenzyme-mediated compound degradation at 1 mM measured within 18 hrs by HPLC method,Other,26216015.0,
256,1259344,1,1,,144205492,638678,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
257,1259355,1,1,,144205492,638678,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
258,1259356,1,1,,144205492,638678,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
259,1259407,1,1,,363900543,638678,Inactive,,,,,CCRIS mutagenicity studies,Other,,
